VINC on the 15 minute chart was sideways at the top and put in a 20% short trade today which was straightforward an easy. A 50% partial taken off at the mid-day counter trend then the remainder of 50% off before the close. Idea is on the chart; see also the previous ideas. Expecting a full reversal in the pre-market trading and a good intraday trade at least...
VINC was a penny stock and is now in the near penny category as this biotech stock has had a great run in the past 10 days. On the 30 minute chart, 225 shares are bought at low prices and 125 shares are sold for profit with 100 shares still running as the momentum slows. Overall, the trades where profitable averaging 12% daily in an average trade of 4.5...
VINC went from 1.5 to 3.0 in less than three hours with 12X relative volume in the afternoon after a month of a slow climb from a news release that really did not amount to much. Insiders are 25% of the shareholders and that may be the story here. This could be manipulation at its finest. I have to wonder how many insiders bought how many shares and when the...
Here on the 30-minute chart is my idea for the continuation of my VINC idea posted here before the current breakout. Price is presently in a consolidation ascending regression channel . The choices for a play are to wait for a break above or below the channel or alternatively play the price action inside the channel. Since price is currently at the bottom of...
With many pharma stocks with even larger market caps going up x10 over a 2 month period, this one can do x20.
VINC $VINC Looks like it's about to break out. Look for the retest of the trendline before going in.
Very little to be found on this one fundamentally, as to what the catalyst could be. But SEC forms show numerous insiders (including CEO) buying before Christmas. Today, analyst Geulah Livshits from Chardan Capital released a buy rating with a PT of 33.